A drug created and manufactured by Advancer Enterprises, it entered Advancer's pharmaceutical catalog in late YE 45. A complex, groundbreaking medication primarily designed for the treatment of severe traumatic injuries
»Optional Image« | |
Year Created: | YE 45 |
Designer / Manufacturer: | Advancer Enterprises |
Nomenclature: | AE-N1 |
Price: | 50 KS per 10ml vial |
Arievadine was conceived in the crucible of conflict, specifically the Second Mishhuvurthyar War and Kuvexian War. Recognizing the urgent need for rapid and effective treatment of traumatic injuries, Advancer Enterprises mobilized its best scientists and resources. The project was fast-tracked, thanks to significant funding from both private and governmental sectors. After years of rigorous research, clinical trials, and ethical reviews, Arievadine was finally submitted for Imperial approval in late YE 45.
Arievadine is a multi-faceted medication designed to accelerate the body's natural healing processes. It stimulates the production of essential proteins like collagen and fibrin, which are crucial for tissue repair and blood vessel regeneration. This makes Arievadine an invaluable asset in the treatment of both minor and severe traumatic injuries, reducing the healing time and minimizing long-term complications such as scarring.
The drug comes in 10ml vials, with a standard dosage of 2ml administered intravenously. For more severe injuries, a dosage of up to 4ml may be used under strict medical supervision. The pricing is set at 75 KS per 10ml vial, reflecting the drug's high production costs and its unparalleled efficacy.
While Arievadine is generally well-tolerated, it does come with its set of risks. The most common side effects include fluctuating blood pressure, nausea, and vomiting. These are usually transient but require immediate medical attention. The drug's rapid tissue repair mechanisms can also lead to temporary confusion in some patients, necessitating close monitoring during the initial stages of treatment.
An overdose of Arievadine can have severe consequences, including the risk of hyperstimulating the body's repair mechanisms. This could lead to abnormal cell growth and even tumorigenesis. The overdose threshold is set at approximately 6ml, three times the standard dosage. Immediate medical intervention, including the administration of counteracting agents and supportive care, is essential in such cases.
Demibear created this article on 2023/10/08 07:47.
Approval Thread: https://stararmy.com/roleplay-forum/threads/advancer-enterprises-white-lion-type-45-vehicle-aid-kit.71051/
Drugs, Medicines, and Pharmaceuticals | |
---|---|
Drug Name(s) | Arievadine |
Route of Administration | intravenous (IV) |
Drug Class | Metabolism enhancers |
Products & Items Database | |
---|---|
Product Categories | drugs |
Product Name | Arievadine |
Nomenclature | AE-N1 |
Manufacturer | Advancer Enterprises |
Year Released | YE 45 |
Price (KS) | 50.00 KS |